The relationship between paraoxanase gene Leu-Met (55) and Gln-Arg (192) polymorphisms and coronary artery disease; [Paraoksonaz geninde Leu-Met (55) ve Gln-Arg (192) polimorfizmleri ile koroner arter hastaliǧi arasindaki ilişki]
dc.contributor.author | Taşkiran P. | |
dc.contributor.author | Çam S.F. | |
dc.contributor.author | Şekuri C. | |
dc.contributor.author | Tüzün N. | |
dc.contributor.author | Alioǧlu E. | |
dc.contributor.author | Altintaş N. | |
dc.contributor.author | Berdeli A. | |
dc.date.accessioned | 2024-07-22T08:21:29Z | |
dc.date.available | 2024-07-22T08:21:29Z | |
dc.date.issued | 2009 | |
dc.description.abstract | Objectives: Paraoxonase (PON1) is a high-density lipoprotein (HDL)-associated esterase that hydrolyses lipoperoxides. PON1 serves as a protective factor against oxidative modification of LDL, suggesting that it may play an important role in the prevention of atherosclerotic process. Research has focused on two polymorphisms: leucine (L allele) to methionine (M allele) substitution at codon 55, and glutamine (A allele) to arginine (B allele) substitution at codon 192. Study design: We examined amino acid changes at codon 55 and 192 in the PON1 gene by polymerase chain reaction and using restriction enzymes in 120 patients (92 men, 28 women; mean age 48.2±4.3 years) with premature coronary artery disease (CAD) and in 102 healthy subjects (80 men, 22 women; mean age 46.8±5.2 years) with no history of CAD and a normal electrocardiogram. Results: Distribution of genotypes in the patient and control groups at codon 55 were 6.7% and 4.9% for MM, 46.7% and 29.4% for LM, 46.7% and 65.7% for LL, respectively. The frequency of genotypes at codon 192 were as follows: 4.2% and 2% for RR, 40% and 35.3% for QR, and 55.8% and 62.8% for QQ, respectively. While the frequency of PON1 55M allele was higher in the CAD group (0.3 vs. 0.2), PON1 192R allele frequency did not differ (0.2). There was a significant relationship between the PON1 M/L55 polymorphism and CAD (p=0.017), whereas the R/Q192 polymorphism was not associated with CAD (p=0.445). Conclusion: These data suggest that the PON1 M/L55 polymorphism shows a significant relationship with CAD and the Q/R192 polymorphism is not a major risk factor causing susceptibility to CAD in our population. | |
dc.identifier.issn | 10165169 | |
dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/18644 | |
dc.language.iso | Turkish | |
dc.subject | Adult | |
dc.subject | Amino Acid Substitution | |
dc.subject | Arginine | |
dc.subject | Aryldialkylphosphatase | |
dc.subject | Codon | |
dc.subject | Coronary Disease | |
dc.subject | DNA Primers | |
dc.subject | Female | |
dc.subject | Gene Frequency | |
dc.subject | Genotype | |
dc.subject | Glutamine | |
dc.subject | Humans | |
dc.subject | Leucine | |
dc.subject | Male | |
dc.subject | Methionine | |
dc.subject | Middle Aged | |
dc.subject | Polymorphism, Genetic | |
dc.subject | arginine | |
dc.subject | aryldialkylphosphatase | |
dc.subject | esterase | |
dc.subject | glutamine | |
dc.subject | high density lipoprotein | |
dc.subject | leucine | |
dc.subject | lipid peroxide | |
dc.subject | low density lipoprotein | |
dc.subject | methionine | |
dc.subject | adult | |
dc.subject | article | |
dc.subject | codon | |
dc.subject | controlled study | |
dc.subject | coronary artery disease | |
dc.subject | DNA polymorphism | |
dc.subject | electrocardiogram | |
dc.subject | female | |
dc.subject | gene | |
dc.subject | gene frequency | |
dc.subject | genotype | |
dc.subject | human | |
dc.subject | hydrolysis | |
dc.subject | major clinical study | |
dc.subject | male | |
dc.subject | polymerase chain reaction | |
dc.subject | risk factor | |
dc.subject | statistical significance | |
dc.title | The relationship between paraoxanase gene Leu-Met (55) and Gln-Arg (192) polymorphisms and coronary artery disease; [Paraoksonaz geninde Leu-Met (55) ve Gln-Arg (192) polimorfizmleri ile koroner arter hastaliǧi arasindaki ilişki] | |
dc.type | Article |